Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society.

Breast Cancer Res · 2022 · PMC8935777 · PMID 35307014

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendP = 0.079so close (0.05 < p ≤ 0.1)

In the IPTW-adjusted cohort, low HER2 expression showed a trend towards better BCSS for TNBC (log-rank test P = 0.079, Additional file 3 : Figure S1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.